|
LIG3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.6075003508389E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.02640000335208E-08 |
| Normal-vs-Stage2 |
1.740130E-03 |
| Normal-vs-Stage3 |
3.52359996735885E-09 |
| Normal-vs-Stage4 |
8.07900000232564E-08 |
| Stage1-vs-Stage2 |
4.275000E-01 |
| Stage1-vs-Stage3 |
1.198580E-01 |
| Stage1-vs-Stage4 |
2.428400E-01 |
| Stage2-vs-Stage3 |
9.689800E-02 |
| Stage2-vs-Stage4 |
1.870210E-01 |
| Stage3-vs-Stage4 |
7.911600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.4777000451337E-09 |
| Normal-vs-AfricanAmerican |
9.981700E-02 |
| Normal-vs-Asian |
2.77800000003658E-06 |
| Caucasian-vs-AfricanAmerican |
1.990070E-02 |
| Caucasian-vs-Asian |
8.498200E-01 |
| AfricanAmerican-vs-Asian |
2.465800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.9979000110435E-09 |
| Normal-vs-Female |
1.05640000080953E-08 |
| Male-vs-Female |
1.557770E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.14610000045978E-07 |
| Normal-vs-Age(41-60Yrs) |
2.3974999985299E-08 |
| Normal-vs-Age(61-80Yrs) |
2.65179999958676E-07 |
| Normal-vs-Age(81-100Yrs) |
1.066350E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.083200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.489600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.627800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.908600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.819600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.493800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.476100E-02 |
| Classical-VS-Follicular |
6.115400E-01 |
| Classical-VS-Other |
1.912440E-01 |
| Classical-VS-Normal |
1.70770000362808E-08 |
| Tall-VS-Follicular |
1.129630E-01 |
| Tall-VS-Other |
8.035200E-01 |
| Tall-VS-Normal |
2.85469999861121E-08 |
| Follicular-VS-Other |
4.055400E-01 |
| Follicular-VS-Normal |
2.37069999999839E-05 |
| Other-VS-Normal |
2.875400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.82749999764343E-08 |
| Normal-vs-N1 |
7.78530000467015E-08 |
| N0-vs-N1 |
1.971050E-01 |
|
|
